News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Mesoblast.
RELATED STOCKHEAD STORIES
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
Weekly ASX small cap wrap: Which ASX stock is hosting a Christmas sleepover?
News
ASX Small Cap Lunch Wrap: Who’s getting the hell out of Dodge today?
Health & Biotech
Mesoblast shares smashed after COVID study setback
News
10 at 10: These ASX stocks have grabbed the most attention this morning
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Mesoblast shares fall on trial’s mixed results with heart injection treatment
Health & Biotech
More evidence for Mesoblast stem cell therapy in graft-versus-host disease
News
ScoPo’s powerplays: ‘Santa is smiling on the markets’
Health & Biotech
Who else on the ASX joins Mesoblast in the fight against ARDS and where are they at?
Health & Biotech
Mesoblast COVID-19 therapy granted fast-track designation
Health & Biotech
Mesoblast in potential $1.7bn partnership with Novartis to develop remestemcel-L
Health & Biotech
The ASX biotech companies that lost puff on Pfizer vaccine news
Health & Biotech
Mesoblast awaits urgent FDA meeting as cash burn continues
News
Last Orders: What you might have missed today on the ASX
News
ASX stocks in America: Opthea’s about to join the ranks but who’s there already?
Health & Biotech
